Status:
NOT_YET_RECRUITING
Evaluation of SureCore Plus Biopsy System
Lead Sponsor:
Uro-1 Medical
Conditions:
BPH
Eligibility:
MALE
18-80 years
Phase:
NA
Brief Summary
This is a post-market study of a cleared biopsy system. The quality of tissue cores varies with standard of care biopsy needles. The SureCore Plus biopsy system is being evaluated as to quality and vo...
Detailed Description
Biopsy sampling of the prostate using TRUS or TPPB guidance is the current SoC approach for diagnosis of prostate cancer (CaP). Over the past decades the number of samples required and considered adeq...
Eligibility Criteria
Inclusion
- Patient has BPH requiring a prostate biopsy
- Able and willing to provide consent
Exclusion
- Active infection
- Subject participating in an other device study of the prostate
Key Trial Info
Start Date :
August 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06550960
Start Date
August 5 2024
End Date
February 1 2025
Last Update
August 13 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.